Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters
Por um escritor misterioso
Descrição
In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.
Viruses, Free Full-Text
Immunological memory to SARS-CoV-2 assessed for up to 8 months
Cross protection to SARS-CoV-2 variants in hamsters with naturally
Resources for Health Professionals
Cross protection to SARS-CoV-2 variants in hamsters with naturally
Imprinted antibody responses against SARS-CoV-2 Omicron
Immunology and Technology of Severe Acute Respiratory Syndrome
Frontiers SARS-CoV-2 Variants, Vaccines, and Host Immunity
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral
Cross protection to SARS-CoV-2 variants in hamsters with naturally
de
por adulto (o preço varia de acordo com o tamanho do grupo)
